New study tests if software can spot dye in liver tumors during radiation

NCT ID NCT05169177

Recruiting now Knowledge-focused Sponsor: University of Sydney Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at images from 50 liver cancer patients who received a special dye (contrast agent) during a procedure before radiation therapy. Researchers want to see if a software program (KIM) can detect that dye in the images to better track the tumor during treatment. The goal is to improve targeting of radiation, not to cure or control the disease directly.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LIVER NEOPLASM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

liver and intrahepatic bile duct neoplasm Liver Neoplasms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LIVER NEOPLASM

Contacts and locations

Locations

Calvary Mater Newcastle Hospital
NOT_YET_RECRUITING

Waratah, New South Wales, 2298, Australia
Peter MacCallum Cancer Centre
NOT_YET_RECRUITING

Melbourne, Victoria, 3000, Australia
Princess Alexandra Hospital
RECRUITING

Woolloongabba, Queensland, 4102, Australia
The Austin Hospital
NOT_YET_RECRUITING

Melbourne, Victoria, 3000, Australia
Westmead Hospital
NOT_YET_RECRUITING

Westmead, New South Wales, 2145, Australia

More trials for these conditions

Other studies related to the condition(s) this trial covers.